Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Vertex Pharmaceuticals
AddedMar 19, 2024
UpdatedJul 9, 2026
Vertex Pharmaceuticals

Vertex Pharmaceuticals

Public

Discovering drugs for serious diseases.

HQ
Boston, MA, US
Founded
1989
Overview
Compare
Fundraising
Employees
Website

Founded in Boston, Massachusetts, Vertex Pharmaceuticals is a biotechnology company dedicated to discovering and commercializing therapies for serious diseases, with a primary focus on cystic fibrosis (CF). The company's core mission is to transform the lives of people with serious diseases through scientific innovation. Vertex markets several CF treatments, including TRIKAFTA/KAFTRIO, SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO, targeting various CF mutations and age groups.

Vertex has garnered significant attention and investment from notable figures in the biotechnology and pharmaceutical industries. The company's groundbreaking work in CF treatment has led to substantial improvements in patient outcomes, earning it a reputation as a leader in the field. Vertex's achievements include the successful commercialization of multiple CF therapies and ongoing research into other serious diseases, underscoring its impact on healthcare and patient lives globally.

Vertex Pharmaceuticals - Similar Companies

PTC Therapeutics logo

PTC Therapeutics

ptcbio.com

Synspira logo

Synspira

Gilead Sciences logo

Gilead Sciences

gilead.com

Vertice Pharma logo

Vertice Pharma

cystetic Medicines logo

cystetic Medicines

Sionna Therapeutics logo

Sionna Therapeutics

sionnatx.com

Astria Therapeutics logo

Astria Therapeutics

astriatx.com

Amylyx Pharmaceuticals logo

Amylyx Pharmaceuticals

amylyx.com

Pulmatrix logo

Pulmatrix

pulmatrix.com

BioCryst Pharmaceuticals logo

BioCryst Pharmaceuticals

biocryst.com

Insmed logo

Insmed

insmed.com

Theravance Biopharma logo

Theravance Biopharma

theravance.com

Boston Biopharma logo

Boston Biopharma

Variant Pharmaceuticals logo

Variant Pharmaceuticals

variantpharma.com

Blueprint Medicines logo

Blueprint Medicines

Vertex Pharmaceuticals - Quick Facts

Who are Vertex Pharmaceuticals' competitors?

Companies similar to Vertex Pharmaceuticals include PTC Therapeutics, Synspira, Gilead Sciences and Vertice Pharma.

When was Vertex Pharmaceuticals founded?

Vertex Pharmaceuticals was founded in 1989.

Where is Vertex Pharmaceuticals' headquarters located?

Vertex Pharmaceuticals' headquarters is located in Boston, MA, US.

When was Vertex Pharmaceuticals' last funding round?

Vertex Pharmaceuticals' most recent funding round was for $50M (USD) in May 2022.

How much has Vertex Pharmaceuticals raised to-date?

As of May 17, 2022, Vertex Pharmaceuticals has raised a total of $656.2M (USD).

How many employees does Vertex Pharmaceuticals have?

Vertex Pharmaceuticals has 4,800 employees as of Feb 6, 2024.

Vertex Pharmaceuticals - Classification

Industry
  • Retail
Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Consumers
  • Enterprise
Main Product
  • CF Treatments
Tags
  • SaaS
Unique IDs
  • secCik: 0000875320
  • ticker: VRTX
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541510Computer Systems Design and Related Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
  • 541511Custom Computer Programming Services
SIC
  • 2800Chemicals And Allied Products
  • 7300Business Services
  • 2830Drugs
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 2834Pharmaceutical Preparations
  • 7371Computer Programming Services
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 18 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 513200Software Publishers
  • 510000Information
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 513000Publishing Industries
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 513210Software Publishers
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research